Carisma Therapeutics Inc. (CARM)

Carisma Therapeutics Inc. (CARM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $20,922; returns 1 day +0.0%.

Carisma Therapeutics Inc. (CARM) is a biopharmaceutical company focused on developing immunotherapies, particularly through its macrophage and monocyte cell engineering platform. However, the company is currently undergoing significant restructuring and a wind-down of operations.

Groups CARM belongs to

• Biotechnology
• Biopharmaceutical
• Immunotherapy
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Oncology
• Life Sciences

CARM financial model: income statement, cash flow and balance sheet